WuXi AppTec Raises Full-Year Revenue Guidance to 35%-39%; H1 Revenue Up 48%, TIDES Up 74.9%
WuXi AppTec released its 2026 interim results and raised its full-year revenue growth guidance to 35%-39%.
Revenue from continuing operations rose 48% year on year in the first half, with adjusted gross margin improving to 53.9%. By segment, the chemistry business grew 61.2% year on year in the second quarter, while TIDES revenue increased 74.9%. Backlog at end-June stood at RMB 66.43 billion, up 25.2% year on year.
The company also raised capital expenditure guidance to RMB 7.5-8.5 billion and brought forward construction of its new Changzhou base.
Why this event matters
The event has a measured impact on 1 industry. The strongest current signal is positive for Pharmaceutical R&D Services, with intensity 82/100 and 85% confidence over a medium term horizon.
Impact figures are analytical estimates that combine direction, intensity, confidence and event importance. They are not investment advice.